Heterogeneity of peripheral blood monocytes, endothelial dysfunction and subclinical atherosclerosis in patients with systemic lupus erythematosus
- 6 August 2015
- journal article
- research article
- Published by SAGE Publications in Lupus
- Vol. 25 (1) , 18-27
Abstract
Systemic lupus erythematosus (SLE) is characterized by increased cardiovascular morbidity and mortality. SLE patients have increased prevalence of subclinical atherosclerosis, although the mechanisms of this observation remain unclear. Considering the emerging role of monocytes in atherosclerosis, we aimed to investigate the relationship between subclinical atherosclerosis, endothelial dysfunction and the phenotype of peripheral blood monocytes in SLE patients. We characterized the phenotype of monocyte subsets defined by the expression of CD14 and CD16 in 42 patients with SLE and 42 non-SLE controls. Using ultrasonography, intima-media thickness (IMT) of carotid arteries and brachial artery flow-mediated dilation (FMD) as well as nitroglycerin-induced dilation (NMD) were assessed. Patients with SLE had significantly, but only modestly, increased IMT when compared with non-SLE controls (median (25th/75th percentile) 0.65 (0.60/0.71) mm vs 0.60 (0.56/0.68) mm; p < 0.05). Importantly, in spite of early atherosclerotic complications in the studied SLE group, marked endothelial dysfunction was observed. CD14dimCD16+proinflammatory cell subpopulation was positively correlated with IMT in SLE patients. This phenomenon was not observed in control individuals. Interestingly, endothelial dysfunction assessed by FMD was not correlated with any of the studied monocyte subsets. Our observations suggest that CD14dimCD16+monocytes are associated with subclinical atherosclerosis in SLE, although the mechanism appears to be independent of endothelial dysfunction.Keywords
This publication has 50 references indexed in Scilit:
- Elevated markers of inflammation and endothelial activation and increased counts of intermediate monocytes in adult survivors of childhood acute lymphoblastic leukemiaImmunobiology, 2013
- Progression of carotid atherosclerosis in patients with systemic lupus erythematosusClinical Rheumatology, 2013
- Targeted anti-inflammatory systemic therapy for restenosis: The Biorest Liposomal Alendronate with Stenting sTudy (BLAST)—a double blind, randomized clinical trialAmerican Heart Journal, 2013
- High plasma leptin levels confer increased risk of atherosclerosis in women with systemic lupus erythematosus, and are associated with inflammatory oxidised lipidsAnnals of the Rheumatic Diseases, 2011
- Systemic lupus erythematosus monocytes are less responsive to interleukin‐10 in the presence of immune complexesArthritis & Rheumatism, 2010
- Prediction of future cardiovascular outcomes by flow-mediated vasodilatation of brachial artery: a meta-analysisThe International Journal of Cardiovascular Imaging, 2010
- Interaction of human peripheral blood monocytes with apoptotic polymorphonuclear cellsImmunology, 2009
- Novel cardiovascular risk factors and cardiac event predictors in female inactive systemic lupus erythematosus patientsClinical Rheumatology, 2006
- Inflammation, Atherosclerosis, and Coronary Artery DiseaseNew England Journal of Medicine, 2005
- Derivation of the sledai. A disease activity index for lupus patientsArthritis & Rheumatism, 1992